Pancreatic Cancer Research

ResearcherWashington University in St. LouisActive in the last 2 years

Varintra E. Lander

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8299-7104; OpenAlex author ID A5052630296; NIH RePORTER profile ID 14625985. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
1
Labs led
0
Collaborators
29
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper, 1 grant · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper

Papers 6

  1. Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer. Co-author DOI 10.1126/sciimmunol.adp3978↗
  2. Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-23-0428↗
  3. Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy. Co-author DOI 10.1084/jem.20212062↗
  4. Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer. Co-author DOI 10.1158/2326-6066.cir-21-0946↗
  5. IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2022.02.035↗
  6. Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer. First author DOI 10.1016/j.ccell.2020.02.008↗

Grants 1

  1. Elucidating the protective role of stromal fibrosis to radiation-induced tumor immunity F30CA243233↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David G DeNardo · 6 shared papers, 2020–2025 · strength 0.87
  2. Ryan C Fields · 5 shared papers, 2020–2025 · strength 0.74
  3. Liang‐I Kang · 4 shared papers, 2022–2025 · strength 0.65
  4. Graham D. Hogg · 4 shared papers, 2020–2025 · strength 0.56
  5. William G. Hawkins · 4 shared papers, 2020–2025 · strength 0.56
  6. John M. Baer · 4 shared papers, 2020–2024 · strength 0.55
  7. Blake E. Sells · 2 shared papers, 2024–2025 · strength 0.36
  8. Jad I. Belle · 2 shared papers, 2023–2024 · strength 0.31
  9. Li Ding · 2 shared papers, 2023–2024 · strength 0.31
  10. C. Alston James · 2 shared papers, 2023 · strength 0.29
  11. Paarth B. Dodhiawala · 2 shared papers, 2022–2023 · strength 0.27
  12. Kian‐Huat Lim · 2 shared papers, 2022–2023 · strength 0.27
  13. Chong Zuo · 2 shared papers, 2020–2023 · strength 0.23
  14. Alyssa G. Weinstein · 1 shared paper, 2025 · strength 0.19
  15. Tiantian Liu · 1 shared paper, 2025 · strength 0.19
  16. Roheena Z. Panni · 1 shared paper, 2025 · strength 0.19
  17. Paolo Provenzano · 1 shared paper, 2024 · strength 0.17
  18. Guhan Qian · 1 shared paper, 2024 · strength 0.17
  19. Hyun Jee Kim · 1 shared paper, 2024 · strength 0.17
  20. Usman Younis Panni · 1 shared paper, 2023 · strength 0.15
  21. Daniel Cui Zhou · 1 shared paper, 2023 · strength 0.14
  22. Patrick M. Grierson · 1 shared paper, 2022 · strength 0.14
  23. Vikas Somani · 1 shared paper, 2022 · strength 0.14
  24. Daoxiang Zhang · 1 shared paper, 2022 · strength 0.14
  25. Lin Li · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.